RedHill Biopharma Ltd (RDHL)

[Amatuer17]

Your target is not very much off but RDHL does not have much market respect so unless it shows Covid results, it is difficult to reach there.

It has 37.4 million shares outstanding - so @ $25 - it will reach a valuation of $1 Billion which is not much with 3 products approved, revenue coming.

But I will be happy if it breaks the $15 barrier and stays there for at least one month. That will form good base.